Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment

Dominik Menges,Michela C. Piatti,Aurelius Omlin,Richard Cathomas,Daniel Benamran,Stefanie Fischer,Christophe Iselin, Marc Küng,Anja Lorch, Lukas Prause,Christian Rothermundt, Alix O'Meara Stern,Deborah Zihler, Max Lippuner,Julia Braun,Thomas Cerny,Milo A. Puhan

European Urology Open Science（2023）

引用 0|浏览4

暂无评分

摘要

There is substantial preference heterogeneity between patients regarding the expected survival benefits and potential adverse effects of systemic treatment for metastatic hormone-sensitive prostate cancer. Patients’ preferences regarding survival and treatment-related adverse effects should be explicitly discussed in clinical practice.

查看译文

关键词

metastatic prostate cancer,general population preferences,prostate cancer,choice

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要